№ lp_2_2_07864
File format: docx
Character count: 2576
File size: 39 KB
Year:
Not specified
Region / City:
Not specified
Theme:
Title IIA funding allocation
Document Type:
Informational sample
Institution:
Massachusetts Department of Elementary and Secondary Education (for reference purposes)
Author:
Not specified
Target Audience:
Educators, school administrators, district leadership
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Note:
Year
Year:
2021
Region / City:
Massachusetts
Theme:
Education, Federal Grants, Teacher Development
Document Type:
Guide
Organization / Institution:
Massachusetts Department of Elementary and Secondary Education (DESE)
Author:
Massachusetts Department of Elementary and Secondary Education (DESE)
Target Audience:
School districts, Grant writers, Fiscal representatives, Education professionals
Period of Effectiveness:
2021-2022
Approval Date:
2021
Date of Revisions:
N/A
Document ID:
MRID No.
Note:
PMRA No.
Report:
Report Citation
Guidelines:
EPA OCSPP Harmonized Test Guideline 860.1300 Nature of the Residue – Plants, Livestock (August 1996)
GLP Compliance:
[No or Significant] deviations from regulatory requirements were reported which would have an impact on the validity of the study. [If “Significant,” then explain below the deficiencies and their impact on the acceptability of the study]
Acceptability:
The study [is/is not] considered scientifically acceptable. [If not acceptable, then explain why below]
Evaluator:
[Name of regulatory person who reviewed the study]
Year:
2007
Region / city:
N/A
Subject:
Metabolism, distribution, and residue expression in livestock
Document type:
Research report
Organization / institution:
OECD, EPA
Author:
N/A
Target audience:
Researchers, regulatory bodies
Period of validity:
N/A
Approval date:
N/A
Amendment date:
N/A
Note:
Year
Topic:
Professional Development
Document Type:
Request Form
Organization / Institution:
Baltimore County Public Schools
Target Audience:
School administrators, teachers
Year:
2026
Subject:
Chemistry
Document type:
Educational worksheet
Target audience:
High school or introductory college students
Content:
Exercises on balancing chemical equations, both formula and word equations
Points possible:
20
Grading scale:
A: 18-20, B: 16-19, C: 14-15, D: 12-13, F: <12
Format:
Written exercises with blanks for answers
Year:
2018–2021
Region / Country:
Iraq, Kenya, Somalia, Northeast Nigeria
Theme:
Humanitarian aid, community engagement, targeting
Document type:
Guidance tool
Organization:
Groupe URD, British Red Cross
Audience:
Humanitarian field workers, National Society staff and volunteers
Sources:
Ground Truth Solutions reports, Participation Handbook for Humanitarian Field Workers, Cash in Emergencies toolkit
Scope:
Community-level selection criteria and targeting
Date:
April 22nd, 2025
Region / City:
Paris, France
Subject:
Immuno-oncology, Biotechnology
Document Type:
Press Release
Organization / Institution:
Egle Therapeutics
Author:
Egle Therapeutics
Target Audience:
Medical and scientific professionals in immuno-oncology and biotechnology
Period of Activity:
2025
Date of Approval:
April 22nd, 2025
Date of Changes:
N/A
Note:
Year
Year:
Not specified
Document type:
Standard Operating Procedure (SOP)
Scope:
Promotional activities for HCPs (excluding samples, direct-to-consumer promotions, product/procedure training)
Applicable audience:
All employees involved in organizing promotional activities
Subject:
Promotion compliance, event sponsorship, HCP engagement, fair market value (FMV), third-party due diligence
Key requirements:
Prohibition of promotion before marketing authorization; restrictions on hospitality, venue, and payments
Effective date / period:
Not specified (mentions international events from January 1, 2018)
Related systems:
EthicalMedTech Conference Vetting System (CVS)
Related documents:
Fee for Service SOP; local procedure for reputational check (Application 1)
Approval status:
Not specified
Revision history:
Section included, details not provided
Year:
2017
Region / City:
KwaZulu-Natal, South Africa
Topic:
HIV prevention, Antiretroviral therapy, Young female-sex workers
Document Type:
Research report, Implementation study
Organization / Institution:
BMJ, StaRI Group
Author:
Pinnock H, Barwick M, Carpenter C, Eldridge S, Grandes G, Griffiths CJ, Rycroft-Malone J, Meissner P, Murray E, Patel A, Sheikh A, Taylor SJC
Target Audience:
Researchers, Healthcare professionals, Public health practitioners
Period of validity:
Not specified
Approval date:
2017
Date of changes:
Not specified
Year:
N/A
Region / City:
N/A
Topic:
Molecular Biology, Cell Biology
Document Type:
Research Figure
Organization / Institution:
N/A
Author:
N/A
Target Audience:
Researchers in molecular biology and microbiology
Period of validity:
N/A
Approval Date:
N/A
Date of changes:
N/A
Context description:
Detailed experimental figures illustrating the effects of different constructs on HeLa cells infected with Chlamydia trachomatis and Coxiella burnetii.
Year:
2021
Region / city:
United States
Topic:
Defense, Military Contracting
Document Type:
Work Statement
Organization / institution:
Lockheed Martin
Author:
Not specified
Target Audience:
Government, Military Personnel
Period of Validity:
Indefinite Delivery/Indefinite Quantity Contract
Approval Date:
Not specified
Date of Changes:
2021
Book Name:
Disease and Health: Research Developments
Manuscript Number:
Ms_BPR_4732
Title of the Manuscript:
Racial Disparity in Quadruple Negative Breast Cancer: Aggressive Biology and Potential Therapeutic Targeting and Prevention
Type of Article:
Book Chapter
Source Article:
Cancers, Volume 14 (Issue 18): 1–15, 2022
DOI:
10.3390/cancers14184484
Journal:
Cancers
Year:
2022
Reviewer:
Sadaf Shafi Gadoo
Reviewer Affiliation:
Government Medical College Srinagar
Country:
India
Subject Area:
Oncology; Breast Cancer Research; Racial Health Disparities
Disease Focus:
Quadruple-Negative Breast Cancer (QNBC)
Population Focus:
Black/African-American Women
Peer Review Outcome:
Scientifically correct; language suitable; references not sufficient or recent
Ethical Issues Reported:
None indicated
Note:
Year
Subject:
Gene Transfer, Targeting, and Therapeutics
Document Type:
Request Form
Organization / Institution:
Salk Institute
Target Audience:
Researchers and Lab personnel
Context:
A form for requesting viral vectors from the Gene Transfer, Targeting, and Therapeutics Facility at the Salk Institute for scientific research purposes.
Year:
2021
Region / City:
Robins AFB, GA
Topic:
Defense, Air Force
Document Type:
Work Statement
Organization:
USAF Precision Attack Integrated Product Team, AFLCMC/WNY
Author:
USAF Precision Attack Integrated Product Team
Target Audience:
Department of Defense (DoD) and U.S. DoD Contractors
Period of Action:
11 Jan 2021
Approval Date:
11 Jan 2021
Amendment Date:
N/A
Year:
2026
Region / City:
La Jolla, CA
Topic:
Gene Transfer, Viral Vectors
Document Type:
Request Form
Organization / Institution:
Salk Institute for Biological Studies
Author:
GT3 Core Facility
Target Audience:
Researchers, Investigators
Validity Period:
N/A
Approval Date:
N/A
Modification Date:
N/A
Year:
2023
Region / City:
Ohio, USA
Topic:
Nanotechnology, RNA Nanoparticles, Cancer Targeting
Document Type:
Research Article
Organization / Institution:
The Ohio State University, Wexner Medical Center
Author:
Hongzhi Wang, Chiran Ghimire, Hui Li, Mario Vieweger, Congcong Xu, Peixuan Guo
Target Audience:
Researchers, Scientists, Medical Professionals
Period of Validity:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Note:
Context
Year:
2023
Region / City:
Not specified
Topic:
Monoclonal antibody sequences, growth rate inhibition in cell models
Document type:
Research Supplementary Material
Organization / Institution:
Not specified
Author:
Not specified
Target audience:
Researchers, biomedical professionals
Effective period:
Not specified
Approval date:
Not specified
Modification date:
Not specified